Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Efficacy and safety of TV-46000, a long-acting, subcutaneous, injectable formulation of risperidone, for schizophrenia: a randomised clinical trial in the USA and Bulgaria

PaperCitations, authors & open-access status

Efficacy and safety of TV-46000, a long-acting, subcutaneous, injectable formulation of risperidone, for schizophrenia: a randomised clinical trial in the USA and Bulgaria is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 31 citations, 2023 year and closed oa status.

31
Citations
2023
Year
closed
OA Status

Related on ScholarIQ

Eran Harary
Author
The Lancet Psychiatry
Journal
Schizophrenia research and treatment
Topic
Schizophrenia research and treatment
Topic
Healthcare Decision-Making and Restraints
Topic
Pharmaceutical studies and practices
Topic
470M+ articles · free account